Stay updated on Dupilumab Efficacy in CRSsNP: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab Efficacy in CRSsNP: Clinical Trial page.

Latest updates to the Dupilumab Efficacy in CRSsNP: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study objectives and inclusion criteria for a clinical trial on dupilumab, while adding a new revision number and registry identifiers.SummaryDifference23%
- Check30 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and has removed the date 2025-03-25 while adding the dates 2025-02-10 and 2024-12-18.SummaryDifference0.5%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new date for the results first posted, now set for March 25, 2025. The previous estimated dates and version have been removed.SummaryDifference0.4%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check80 days agoChange DetectedThe webpage has updated its timeline by removing dates related to Phase 2 and adding new dates for Phase 3, indicating a shift in project phases. Additionally, a new results summary link has been provided.SummaryDifference1.0%
Stay in the know with updates to Dupilumab Efficacy in CRSsNP: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab Efficacy in CRSsNP: Clinical Trial page.